0
Get Alert
Please Wait... Processing your request... Please Wait.
You must sign in to sign-up for alerts.

Please confirm that your email address is correct, so you can successfully receive this alert.

1
FROM THE GUEST EDITOR   |    
From the Guest Editors
Susan G. Kornstein, M.D.; Anita H. Clayton, M.D.
FOCUS 2012;10:1-1. doi:10.1176/appi.focus.10.1.1
View Author and Article Information

Guest Editor Information and CME Disclosure

Susan G. Kornstein, M.D., Professor of Psychiatry and Obstetrics/Gynecology; Medical Director, Professor of Psychiatry and Obstetrics/Gynecology; Executive Director, Institute for Women's Health; Executive Director, Mood Disorders Institute; Medical Director, Clinical Research Services; Center for Clinical and Translational Research; Virginia Commonwealth University; Editor-in-Chief, Journal of Women's Health.

Research Support: Pfizer, Bristol-Myers Squibb, Otsuka, Euthymics, Rexahn, Lilly, Boehringer-Ingelheim, Forest; Consulting: Pfizer, Bristol-Myers Squibb, Lilly, Takeda, Trovis, Rexahn, Dey Pharma, PGx Health.

Anita H. Clayton, M.D., Professor of Psychiatry and Neurobehavioral Sciences, Medical Director, Outpatient Psychiatry Clinic and Center for Psychiatric Clinical Research, University of Virginia School of Medicine.

Grants: Biosante Pharmaceuticals, Palatin Technologies, Pfizer, Takeda; Advisory Board/Consultant: Bayer, Dey Pharma, Eli Lilly, Euthymics, Forest, GlaxoSmithKline, Palatin Technologies, Pfizer, Takeda, Valeant; Royalties/Copyright: Guilford Publications: Changes in Sexual Functioning Questionnaire.

text A A A

This issue of FOCUS contains new developments from the field of women's mental health. A particular challenge for psychiatric practitioners is the assessment and management of psychiatric disorders in women across the reproductive life cycle, including pregnancy, postpartum, and the menopausal transition. In addition, primary care providers and obstetrician/gynecologists often turn to psychiatrists for consultation regarding diagnosis and which treatment approaches are most efficacious and safe for women during these life stages.

The original articles in this issue provide state-of-the-art updates on the epidemiology and management of reproductive mood disorders. Gail Erlick Robinson has contributed an overview of psychopharmacology in pregnancy and postpartum. Rita Suri and Lori Altshuler discuss advances in the recognition and treatment of postpartum depression. Luciano Minuzzi, Benicio Frey, and Claudio Soares review current management strategies for depression during the menopausal transition. The FOCUS regular features, Patient Management exercise by Ian Cook and the Ask the Expert column by Karen Padron and Jeffrey Newport, provide a clinical situation and discussion. Finally, Mytilee Vemuri and Laura Weiss Roberts examine ethical considerations in treating women with mental illness during pregnancy.

In addition to these original articles, we also provide reprints and abstracts of relevant articles in the field, allowing practitioners to gain additional understanding of these important topics. We sincerely hope that the information contained in this issue will equip practitioners with the knowledge and skills that they need to provide the best care possible to their women patients across the lifespan.

+

References

+
+

CME Activity

There is currently no quiz available for this resource. Please click here to go to the CME page to find another.
Submit a Comments
Please read the other comments before you post yours. Contributors must reveal any conflict of interest.
Comments are moderated and will appear on the site at the discertion of APA editorial staff.

* = Required Field
(if multiple authors, separate names by comma)
Example: John Doe